Filtros de búsqueda

Lista de obras de Toby Maher

18F-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: implications for future clinical trials.

artículo científico publicado en 2011

A Clinical Approach to Diffuse Parenchymal Lung Disease ⬇️

artículo científico publicado el 26 de septiembre de 2012

A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK

artículo científico publicado en 2016

A lesson in plasticity: a 74-year-old man with plastic bronchitis

artículo científico publicado en 2017

A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial

artículo científico publicado en 2017

A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor

scientific article published on 26 March 2020

A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis

artículo científico publicado en 2019

Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.

artículo científico publicado en 2016

Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation

artículo científico publicado en 2020

Aerobic Glycolysis and the Warburg Effect. An Unexplored Realm in the Search for Fibrosis Therapies?

artículo científico publicado en 2015

Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial

artículo científico publicado en 2017

Ambulatory oxygen in interstitial lung disease

scientific article published on 01 October 2011

An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study.

artículo científico publicado en 2017

An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study.

artículo científico publicado en 2014

Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone.

artículo científico publicado en 2017

Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis.

artículo científico publicado en 2016

Anti-acid treatment in patients with IPF: interpret results from post-hoc, subgroup, and exploratory analyses with great caution - Authors' reply.

artículo científico publicado en 2016

Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat

scientific article published on 06 September 2019

Author Correction: The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis

scientific article published on 11 September 2020

Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent

artículo científico publicado en 2020

Beyond the diagnosis of idiopathic pulmonary fibrosis; the growing role of systems biology and stratified medicine ⬇️

artículo científico publicado el 1 de septiembre de 2013

Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort

scientific article published on 12 July 2019

Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study

scientific article published on 17 July 2019

Blood-based Diagnosis of Idiopathic Pulmonary Fibrosis. Fantasy or Reality?

artículo científico publicado en 2016

Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia

artículo científico publicado en 2014

Bronchoalveolar Lavage is Safe and Well Tolerated in Individuals with Idiopathic Pulmonary Fibrosis: An Analysis of the PROFILE Study

artículo científico publicado en 2020

CT findings of varicella pneumonia after lung transplantation

artículo científico publicado en 2007

Can monocytes predict prognosis of idiopathic pulmonary fibrosis?

scientific article published on 29 March 2019

Case-based discussion from the Royal Devon and Exeter NHS Foundation Trust: a painful paradox

artículo científico publicado en 2014

Challenges in the classification of fibrotic ILD.

artículo científico

Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis.

artículo científico publicado en 2017

Chronic hypersensitivity pneumonitis; an enigmatic and frequently fatal disease

artículo científico publicado en 2020

Clinical quantification of the integrin αvβ6 by [18F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study)

artículo científico publicado en 2019

Clinical trial research in focus: why do so many clinical trials fail in IPF?

artículo científico publicado en 2017

Combination Therapy and the Start of a New Epoch for Idiopathic Pulmonary Fibrosis?

artículo científico publicado en 2017

Combination therapy: the future of management for idiopathic pulmonary fibrosis?

artículo científico publicado en 2014

Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis: The Future of Quantitative Analysis

artículo científico publicado en 2019

Cost-effectiveness of ambulatory oxygen in improving quality of life in fibrotic lung disease: preliminary evidence from the AmbOx Trial

scientific article published on 06 February 2020

Cough Severity Visual Analogue Scale Assesses Cough Burden and Predicts Survival in Idiopathic Pulmonary Fibrosis

artículo científico publicado en 2024

Cough in fibrotic lung disease: An unresolved challenge

artículo científico publicado en 2017

Could quality be the key in connective tissue disease-associated interstitial lung disease?

artículo científico publicado en 2018

Current and Future Therapies for Idiopathic Pulmonary Fibrosis

Current and future perspectives on management of systemic sclerosis-associated interstitial lung disease

artículo científico publicado en 2019

Current and novel drug therapies for idiopathic pulmonary fibrosis

artículo científico publicado en 2012

Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis

artículo científico publicado en 2013

Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary Fibrosis.

scientific article published on 18 April 2016

Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease

scientific article published on 08 January 2020

Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™).

artículo científico publicado en 2017

Detecting anxiety and depression in patients diagnosed with an interstitial lung disease. Can we do better?

artículo científico publicado en 2014

Development of a Consensus Statement for the Definition, Diagnosis, and Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis Using the Delphi Technique.

artículo científico publicado en 2015

Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis

scientific article published on 01 November 2019

Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study.

artículo científico publicado en 2017

Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype

artículo científico publicado en 2020

Differential Expression of VEGF-Axxx Isoforms Is Critical for Development of Pulmonary Fibrosis

artículo científico publicado en 2017

Diffuse cystic lung disease of unexplained cause with coexistent small airway disease: a possible causal relationship?

artículo científico publicado en 2012

Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis

artículo científico publicado en 2010

Disease stratification in idiopathic pulmonary fibrosis: the dawn of a new era?

artículo científico publicado en 2014

Diverse functions of clusterin promote and protect against the development of pulmonary fibrosis.

artículo científico publicado en 2018

Drug-/radiation-induced interstitial lung disease in the United Kingdom general population: incidence, all-cause mortality and characteristics at diagnosis.

artículo científico

Dynamics of human monocytes and airway macrophages during healthy aging and after transplant

scientific article published on 01 March 2020

Effect of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) vs Placebo on Death, Lung Transplant, or Hospital Admission in Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis: The EME-TIPAC Randomized Clinical Trial

artículo científico publicado en 2020

Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial

scientific article published on 28 August 2018

Effect of nintedanib on lung function in patients with systemic sclerosis-associated interstitial lung disease: further analyses of the SENSCIS trial

artículo científico publicado en 2020

Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis

artículo científico publicado en 2016

Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial

artículo científico publicado en 2021

Elevated nocturnal desaturation index predicts mortality in interstitial lung disease

artículo científico publicado el 1 de marzo de 2012

Epigenetic regulation of cyclooxygenase-2 by methylation of c8orf4 in pulmonary fibrosis

artículo científico publicado en 2016

Erratum to: Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events.

artículo científico publicado en 2014

Estimating the effect of nintedanib on forced vital capacity in children and adolescents with fibrosing interstitial lung disease using a Bayesian dynamic borrowing approach

artículo científico publicado en 2024

Evidence for a functional thymic stromal lymphopoietin signaling axis in fibrotic lung disease

artículo científico publicado en 2013

Exercise-induced haemoptysis: a thoroughbred cause? ⬇️

artículo científico publicado el 12 de febrero de 2013

Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF

artículo científico publicado en 2016

Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis.

artículo científico publicado en 2017

Gait speed and prognosis in patients with idiopathic pulmonary fibrosis: a prospective cohort study

scientific article published on 07 February 2019

Gazing into the crystal ball: can treatment response be predicted in IPF?

scientific article published on 29 June 2018

Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.

artículo científico publicado en 2017

Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis

scientific article published on 01 March 2020

Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis

scientific journal article

Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia

artículo científico publicado en 2016

Health-related quality of life and symptoms in patients with IPF treated with nintedanib: analyses of patient-reported outcomes from the INPULSIS® trials

artículo científico publicado en 2020

Healthcare Resource Utilization Among Patients in England with Systemic Sclerosis-Associated Interstitial Lung Disease: A Retrospective Database Analysis

scientific article published on 21 April 2020

Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA

scientific article published on 21 May 2020

Home spirometry for idiopathic pulmonary fibrosis: ready for prime time?

artículo científico publicado en 2017

Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial

artículo científico publicado en 2021

Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis.

artículo científico publicado en 2017

Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis

artículo científico publicado en 2021

Identifying Barriers to Idiopathic Pulmonary Fibrosis Treatment: A Survey of Patient and Physician Views

artículo científico publicado en 2018

Idiopathic Pulmonary Fibrosis: New and Emerging Treatment Options

artículo científico publicado en 2019

Idiopathic Pulmonary Fibrosis: Pathobiology of Novel Approaches to Treatment ⬇️

artículo científico publicado el 28 de diciembre de 2011

Idiopathic pulmonary fibrosis-related pulmonary hypertension; an exercising diagnosis?

scientific article published on 01 April 2011

Idiopathic pulmonary fibrosis: Disease mechanisms and drug development

scientific article published on 20 December 2020

Idiopathic pulmonary fibrosis: Recent advances on pharmacological therapy

artículo científico

If it was good enough for Aristotle......

scientific article published on 13 January 2011

Immunosuppression for connective tissue disease-related pulmonary disease.

artículo científico

Improved correction for the tissue fraction effect in lung PET/CT imaging

artículo científico publicado en 2015

Improved quantitation and reproducibility in multi-PET/CT lung studies by combining CT information.

artículo científico publicado en 2018

In patients with idiopathic pulmonary fibrosis the presence of hiatus hernia is associated with disease progression and mortality

scientific article published on 23 May 2019

In search of the fibrotic epithelial cell: opportunities for a collaborative network.

artículo científico publicado en 2011

Incidence of the pneumoconioses in the United Kingdom general population between 1997 and 2008.

artículo científico

Incidence, Prevalence, and Survival of Patients with Idiopathic Pulmonary Fibrosis in the UK.

artículo científico publicado en 2018

Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury.

artículo científico publicado en 2009

Influence of Idiopathic Pulmonary Fibrosis Progression on Healthcare Resource Use

scientific article published on 01 March 2019

Interaction between the promoter MUC5B polymorphism and mucin expression: is there a difference according to ILD subtype?

artículo científico publicado en 2020

Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis

artículo científico publicado en 2019

Interstitial lung disease in systemic sclerosis: a simple staging system

artículo científico publicado en 2008

Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial

artículo científico publicado en 2018

Itaconate controls the severity of pulmonary fibrosis

artículo científico publicado en 2020

King's Brief Interstitial Lung Disease questionnaire: responsiveness and minimum clinically important difference

scientific article published on 05 September 2019

Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysema

artículo científico publicado en 2017

Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis

artículo científico

Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study

scientific article published on 19 October 2018

Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study

artículo científico publicado en 2015

Longitudinal prediction of outcome in idiopathic pulmonary fibrosis using automated CT analysis

artículo científico publicado en 2019

Lost in translation; from animal models of pulmonary fibrosis to human disease

artículo científico publicado en 2009

Lung function outcomes in the INPULSIS® trials of nintedanib in idiopathic pulmonary fibrosis

scientific article published on 19 November 2018

Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q).

artículo científico publicado en 2009

Management of Fibrosing Interstitial Lung Diseases

artículo científico publicado en 2019

Mapping the future for pulmonary fibrosis: report from the 17th International Colloquium on Lung and Airway Fibrosis

artículo científico publicado en 2013

Medicine and Me: a breath of fresh air for IPF.

artículo científico publicado en 2016

Metformin Does Not Affect Clinically Relevant Outcomes in Patients with Idiopathic Pulmonary Fibrosis

artículo científico publicado en 2018

Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease.

artículo científico publicado en 2013

Mixed ventilatory defects in pulmonary sarcoidosis: prevalence and clinical features

artículo científico publicado en 2020

Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design

scientific article published on 29 September 2019

Morphine for treatment of cough in idiopathic pulmonary fibrosis (PACIFY COUGH): a prospective, multicentre, randomised, double-blind, placebo-controlled, two-way crossover trial

artículo científico publicado en 2024

Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis

artículo científico publicado en 2013

Native valve Aspergillus endocarditis complicating lung transplantation

artículo científico publicado en 2008

New guideline on treatment of idiopathic pulmonary fibrosis

artículo científico publicado en 2015

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease. Reply

scientific article published on 01 October 2019

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

artículo científico publicado en 2019

Nintedanib in idiopathic pulmonary fibrosis.

artículo científico

Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume

artículo científico publicado en 2016

No relevant pharmacokinetic drug-drug interaction between nintedanib and pirfenidone

scientific article published on 10 January 2019

Novel use of rituximab in hypersensitivity pneumonitis refractory to conventional treatment.

artículo científico publicado en 2013

Obliterative bronchiolitis in fibreglass workers: a new occupational disease?: Table 1 ⬇️

artículo científico publicado el 15 de enero de 2013

Opportunities to diagnose fibrotic lung diseases in routine care: A primary care cohort study

scientific article published on 11 May 2020

Overlap of Genetic Risk between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis

scientific article published on 01 December 2019

PD-1 up-regulation on CD4 T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production

artículo científico publicado en 2018

PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery ⬇️

artículo científico publicado el 1 de junio de 2013

Patient eligibility for anti-fibrotic therapy in idiopathic pulmonary fibrosis can be altered by use of different sets of reference values for calculation of FVC percent predicted

artículo científico publicado en 2016

Patient-reported distress can aid clinical decision-making in idiopathic pulmonary fibrosis: analysis of the PROFILE cohort

artículo científico publicado en 2019

Personalized medicine in idiopathic pulmonary fibrosis: facts and promises

artículo científico

Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives

artículo científico publicado en 2015

Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis

scientific article published on 02 October 2020

Phenotypic characteristics associated with slow gait speed in idiopathic pulmonary fibrosis

artículo científico publicado en 2017

Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease

artículo científico publicado en 2020

Pirfenidone Treatment in Individuals with Idiopathic Pulmonary Fibrosis: Impact of Timing of Treatment Initiation

artículo científico publicado en 2019

Pirfenidone in idiopathic pulmonary fibrosis.

artículo científico publicado en 2010

Pirfenidone in idiopathic pulmonary fibrosis: expert panel discussion on the management of drug-related adverse events

artículo científico publicado en 2014

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial

scientific article published on 29 September 2019

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial

artículo científico publicado en 2018

Pleuroparenchymal Fibroelastosis: A Review of Histopathologic Features and the Relationship Between Histologic Parameters and Survival

artículo científico publicado en 2017

Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact

artículo científico publicado en 2020

Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes.

artículo científico publicado en 2012

Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases

artículo científico publicado en 2019

Precision medicine in idiopathic pulmonary fibrosis.

artículo científico publicado en 2016

Predicting Life Expectancy for Pirfenidone in Idiopathic Pulmonary Fibrosis

artículo científico publicado en 2017

Predicting Outcomes in Idiopathic Pulmonary Fibrosis Using Automated Computed Tomographic Analysis

scientific article published on 01 September 2018

Predicting outcomes in rheumatoid arthritis related interstitial lung disease

artículo científico publicado en 2019

Predictors of progression in systemic sclerosis patients with interstitial lung disease

artículo científico publicado en 2020

Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.

artículo científico publicado en 2016

Prevalence and Effects of Emphysema in Never-Smokers with Rheumatoid Arthritis Interstitial Lung Disease.

artículo científico publicado en 2018

Primary endpoints in phase 3 clinical trials in idiopathic pulmonary fibrosis: one step at a time.

artículo científico publicado en 2013

Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities

scientific article published on 03 January 2019

Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities

artículo científico publicado en 2019

Proportion of Idiopathic Pulmonary Fibrosis Risk Explained by Known Common Genetic Loci in European Populations

artículo científico publicado en 2020

Provision of home mechanical ventilation and sleep services for England survey.

artículo científico publicado en 2013

Pulmonary 18F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF).

artículo científico publicado en 2018

Pulmonary Langerhans cell histiocytosis (PLCH): a new UK register.

artículo científico publicado en 2014

Pulmonary Macrophages: A New Therapeutic Pathway in Fibrosing Lung Disease?

artículo científico publicado en 2016

Pulmonary fibrosis associated with psychotropic drug therapy: a case report.

artículo científico publicado en 2009

Pulmonary fibrosis secondary to COVID-19: a call to arms?

scientific article published on 15 May 2020

Pulmonary function vascular index predicts prognosis in idiopathic interstitial pneumonia

artículo científico publicado en 2012

Pulmonary hypertension in interstitial lung disease: Limitations of echocardiography compared to cardiac catheterization.

artículo científico publicado en 2018

Rapidly Progressive Cystic Lung Disease

artículo científico publicado en 2018

Rasch analysis and impact factor methods both yield valid and comparable measures of health status in interstitial lung disease

artículo científico publicado en 2015

Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2).

artículo científico publicado en 2019

Recent advances in understanding idiopathic pulmonary fibrosis

artículo científico publicado en 2016

Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib

artículo científico publicado en 2013

Regularized Latent Class Model for Joint Analysis of High-Dimensional Longitudinal Biomarkers and a Time-to-Event Outcome

artículo científico publicado en 2018

Reply to Fujimoto <i>et al.</i>: The Need for a CYFRA 21-1 Cutoff Value to Predict Clinical Progression of IPF in Clinical Practice

artículo científico publicado en 2022

Reply: Daily Home Spirometry: A New Milestone in the Field of Pulmonary Fibrosis.

artículo científico publicado en 2016

Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis

artículo científico publicado en 2019

Respiratory microbiome in IPF: cause, effect, or biomarker?

artículo científico publicado en 2014

Rituximab in severe, treatment-refractory interstitial lung disease.

artículo científico publicado en 2013

Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial.

artículo científico publicado en 2017

Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practice

artículo científico publicado en 2018

Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial

artículo científico publicado en 2020

Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial

artículo científico publicado en 2018

Sarcoidosis in the UK: insights from British Thoracic Society registry data

scientific article published on 18 February 2019

Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis.

artículo científico publicado en 2013

Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression

artículo científico publicado en 2020

Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy

scientific article published on 26 January 2012

Shedding light on developmental drugs for idiopathic pulmonary fibrosis

artículo científico publicado en 2020

Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis.

artículo científico publicado en 2017

Significance of connective tissue disease features in idiopathic interstitial pneumonia.

artículo científico publicado en 2011

Statin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary Fibrosis.

artículo científico publicado en 2018

Successful treatment of progressive diffuse PEComatosis

artículo científico publicado en 2012

Survival in Idiopathic Pulmonary Fibrosis: Perspectives from Pulmonary Arterial Hypertension

artículo científico publicado en 2017

Target-inhibition of Galectin-3 by Inhaled TD139 in Patients with Idiopathic Pulmonary Fibrosis

artículo científico publicado en 2020

The Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review.

artículo científico publicado en 2018

The Efficacy and Mechanism Evaluation of Treating Idiopathic Pulmonary fibrosis with the Addition of Co-trimoxazole (EME-TIPAC): study protocol for a randomised controlled trial.

artículo científico publicado en 2018

The King's Brief Interstitial Lung Disease (KBILD) questionnaire: an updated minimal clinically important difference

scientific article published on 18 February 2019

The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis is Distinct from that of Idiopathic Pulmonary Fibrosis

artículo científico publicado en 2020

The Role of the Lung's Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis

scientific article published on 10 November 2019

The Transferrin Receptor CD71 Delineates Functionally Distinct Airway Macrophage Subsets during Idiopathic Pulmonary Fibrosis

scientific article published on 01 July 2019

The causal relationship between gastro-oesophageal reflux disease and idiopathic pulmonary fibrosis: a bidirectional two-sample Mendelian randomisation study

artículo científico publicado en 2023

The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire

artículo científico publicado en 2012

The development and validation of the King's Sarcoidosis Questionnaire for the assessment of health status.

artículo científico publicado en 2012

The diagnosis of idiopathic pulmonary fibrosis and its complications ⬇️

artículo científico publicado el 1 de diciembre de 2008

The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis.

artículo científico publicado en 2017

The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements ⬇️

artículo científico publicado en 2020

The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis

artículo científico publicado en 2019

The minimal important difference of the King's Brief Interstitial Lung Disease Questionnaire (K-BILD) and forced vital capacity in interstitial lung disease

artículo científico publicado en 2013

The need for a holistic approach for SSc-ILD - achievements and ambiguity in a devastating disease

scientific article published on 23 July 2020

The potential impact of azithromycin in idiopathic pulmonary fibrosis

scientific article published on 14 February 2019

The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis

artículo científico publicado en 2014

The role of infection in the pathogenesis of idiopathic pulmonary fibrosis.

artículo científico publicado en 2013

The topical study of inhaled drug (salbutamol) delivery in idiopathic pulmonary fibrosis

artículo científico publicado en 2018

The treatment of idiopathic pulmonary fibrosis.

artículo científico publicado en 2014

Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?

artículo científico publicado en 2018

Time for an International Consensus on Hypersensitivity Pneumonitis. A Call to Arms.

artículo científico publicado en 2017

Towards a global initiative for fibrosis treatment (GIFT).

artículo científico publicado en 2017

Transcriptional phenotyping of fibrotic lung disease: a new gold standard?

artículo científico publicado en 2015

Transcriptome analysis of IPF fibroblastic foci identifies key pathways involved in fibrogenesis

artículo científico publicado en 2020

Translational pharmacology of an inhaled small molecule αvβ6 integrin inhibitor for idiopathic pulmonary fibrosis

scientific article published on 16 September 2020

Treatment of Acute Exacerbation of IPF - A Call to Arms

scientific article published on 24 January 2020

Treatment of sarcoidosis-associated pulmonary hypertension: A single centre retrospective experience using targeted therapies

artículo científico publicado en 2014

UK trainee experience in interstitial lung disease: results from a British Thoracic Society survey

artículo científico publicado en 2014

Understanding nonspecific interstitial pneumonia: the need for a diagnostic gold standard

artículo científico publicado en 2009

Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis

artículo científico publicado en 2016

Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis: methodological concerns

artículo científico publicado en 2016

Unmet needs in the treatment of idiopathic pulmonary fibrosis-insights from patient chart review in five European countries

artículo científico publicado en 2017

Update in Interstitial Lung Disease 2016.

artículo científico publicado en 2017

Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study.

artículo científico publicado en 2017

Validity, responsiveness and minimum clinically important difference of the incremental shuttle walk in idiopathic pulmonary fibrosis: a prospective study.

artículo científico publicado en 2017

Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis

scientific article published on 25 July 2019

Vascular density does not predict future metastatic disease in clinical stage 1 non‐seminomatous germ cell tumours of the testis ⬇️

artículo científico publicado el 1 de marzo de 1998

Year in review 2009: Interstitial lung diseases, acute injury, sleep, physiology, imaging and bronchoscopic intervention.

artículo científico publicado en 2010

Year in review 2010: interstitial lung diseases, acute lung injury, sleep, physiology, imaging, bronchoscopic intervention and lung cancer

artículo científico publicado en 2011

Year in review 2011: acute lung injury, interstitial lung diseases, physiology, sleep and lung cancer

artículo científico

Year in review 2012: acute lung injury, interstitial lung diseases, sleep and physiology

artículo científico

Year in review 2013: Acute lung injury, interstitial lung diseases, sleep and physiology.

artículo científico publicado en 2014

Year in review 2014: Interstitial lung disease, physiology, sleep and ventilation, acute respiratory distress syndrome, cystic fibrosis, bronchiectasis and rare lung disease

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda